CAT and type 2 diabetes mellitus: In line with these reports, catalase treatment of platelets from patients with type 2 diabetes mellitus increased the PMCA tyrosine phosphorylation induced by thapsigargin plus ionomycin, suggesting that oxidative stress is involved in the reduced platelet PMCA activity seen in diabetic patients [34].